{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:43:41Z","timestamp":1791031421375,"version":"4.1.0"},"reference-count":25,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,11,1]]},"abstract":"<jats:p>Objectives. To determine the extent of unlicensed and off-label drugs prescribed in the level 3 neonatal intensive care unit (NICU) at the Royal Women\u2019s Hospital, Melbourne, Australia.<\/jats:p>\n                  <jats:p>Methods. A prospective cohort study was conducted of all infants who were admitted to the NICU during a 10-week period. Each drug prescribed was evaluated in relation to the licensed approved uses to determine whether the drug was administered in a licensed manner or was unlicensed or used in an off-label manner.<\/jats:p>\n                  <jats:p>Results. There were a total of 101 admissions involving 97 infants. A total of 1442 prescriptions were administered; 42% were licensed, 11% were unlicensed, and 47% were off-label. Twenty-one percent were off-label for 2 or more reasons. Eighty percent of infants received either an unlicensed or an off-label prescription or both; this proportion rose to 93% of extremely low birth weight infants.<\/jats:p>\n                  <jats:p>Conclusions. This is the largest study performed of unlicensed and off-label drug use in the NICU. This practice remains widespread despite clear recommendations to improve this undesirable situation. The attendant risks to infants and prescribers remain. It is time for legislation to be introduced to govern this area.<\/jats:p>","DOI":"10.1542\/peds.110.5.e52","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T20:17:55Z","timestamp":1092428275000},"page":"e52-e52","source":"Crossref","is-referenced-by-count":103,"title":["Unlicensed and Off-Label Drug Use in an Australian Neonatal Intensive Care Unit"],"prefix":"10.1542","volume":"110","author":[{"given":"Colm P. F.","family":"O\u2019Donnell","sequence":"first","affiliation":[{"name":"From the Neonatal Unit, Royal Women\u2019s Hospital, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn J.","family":"Stone","sequence":"additional","affiliation":[{"name":"From the Neonatal Unit, Royal Women\u2019s Hospital, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin J.","family":"Morley","sequence":"additional","affiliation":[{"name":"From the Neonatal Unit, Royal Women\u2019s Hospital, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2002,11,1]]},"reference":[{"key":"2021121006391947600_R1","unstructured":"Turner S, Nunn AJ, Choonara I. Unlicensed drug use in children in the UK. Paediatr Perinat Drug Ther.1997;1:52\u201355"},{"key":"2021121006391947600_R2","doi-asserted-by":"crossref","unstructured":"Turner S. Unregistered and off-label drug use in paediatric inpatients. Aust J Hosp Pharm.1999;29:265\u2013268","DOI":"10.1002\/jppr1999295265"},{"key":"2021121006391947600_R3","doi-asserted-by":"crossref","unstructured":"Gershanik J, Boecler B, Ensley H, McCloskey S, George W. The gasping syndrome and benzyl alcohol poisoning. N Engl J Med.1982;307:1384\u20131388","DOI":"10.1056\/NEJM198211253072206"},{"key":"2021121006391947600_R4","unstructured":"Australian Drug Evaluation Committee. Report of the Working Party on the Registration of Drugs for Use in Children. Canberra, Australia: Therapeutic Goods Administration; 1997"},{"key":"2021121006391947600_R5","doi-asserted-by":"crossref","unstructured":"Blumer JL. Off-label uses of drugs in children. Pediatrics.1999;104:598\u2013602","DOI":"10.1542\/peds.104.S3.598"},{"key":"2021121006391947600_R6","doi-asserted-by":"crossref","unstructured":"Shirkey H. Therapeutic orphans [editorial]. J Pediatr.1968:72;119\u2013120","DOI":"10.1016\/S0022-3476(68)80414-7"},{"key":"2021121006391947600_R7","doi-asserted-by":"crossref","unstructured":"\u2019t Jong GW, Vulto AG, de Hoog M, Schimmel KJ, Tibboel D, van den Anker JN. A survey of the use of off-label and unlicensed drugs in a Dutch children\u2019s hospital. Pediatrics.2001;108:1089\u20131093","DOI":"10.1542\/peds.108.5.1089"},{"key":"2021121006391947600_R8","doi-asserted-by":"crossref","unstructured":"\u2019t Jong GW, Vulto AG, de Hoog M, Schimmel KJ, Tibboel D, van den Anker JN. Unapproved and off-label use of drugs in a children\u2019s hospital. N Engl J Med.2000;343:112","DOI":"10.1056\/NEJM200010123431515"},{"key":"2021121006391947600_R9","doi-asserted-by":"crossref","unstructured":"Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off-label drug use in paediatric wards in European countries. BMJ.2000;320:79\u201382","DOI":"10.1136\/bmj.320.7227.79"},{"key":"2021121006391947600_R10","doi-asserted-by":"crossref","unstructured":"Turner S, Longworth A, Nunn AJ, Choonara I. Unlicensed and off-label drug use in paediatric wards: prospective study. BMJ.1998;315:343\u2013345","DOI":"10.1136\/bmj.316.7128.343"},{"key":"2021121006391947600_R11","unstructured":"Craig JS, Henderson CR, Magee FA. The extent of unlicensed and off-label drug use in the paediatric ward of a district general hospital in Northern Ireland. Ir Med J.2001;94:237\u2013240"},{"key":"2021121006391947600_R12","doi-asserted-by":"crossref","unstructured":"Pandolfini C, Impicciatore P, Provasi D, Rocchi F, Campi R, Bonati M. Off-label use of drugs in Italy: a prospective, observational and multicentre study. Acta Paediatr.2002;91:339\u2013347","DOI":"10.1111\/j.1651-2227.2002.tb01726.x"},{"key":"2021121006391947600_R13","doi-asserted-by":"crossref","unstructured":"Chalumeau M, Treluyer JM, Salanave B, et al. Off label and unlicensed drug use among French office based paediatricians. Arch Dis Child.2000;83:502\u2013505","DOI":"10.1136\/adc.83.6.502"},{"key":"2021121006391947600_R14","doi-asserted-by":"crossref","unstructured":"McIntyre J, Conroy S, Avery A, Corns H, Choonara I. Unlicensed and off-label prescribing of drugs in general practice. Arch Dis Child.2000;83:498\u2013501","DOI":"10.1136\/adc.83.6.498"},{"key":"2021121006391947600_R15","doi-asserted-by":"crossref","unstructured":"Bu\u0308cheler R, Schwab M, Mo\u0308rike K, et al. Off label prescribing to children in primary care in Germany: retrospective cohort study. BMJ.2002;324:1311\u20131312","DOI":"10.1136\/bmj.324.7349.1311"},{"key":"2021121006391947600_R16","doi-asserted-by":"crossref","unstructured":"Schirm E, Tobi H, de Jong-van den Berg LTW. Unlicensed and off label drug use by children in the community: cross sectional study. BMJ.2002;324:1312\u20131313","DOI":"10.1136\/bmj.324.7349.1312"},{"key":"2021121006391947600_R17","doi-asserted-by":"crossref","unstructured":"\u2019t Jong GW, Eland IA, Sturkenboom MCJM, van den Anker JN, Stricker BHCh. Unlicensed and off label prescription of drugs to children: population based cohort study. BMJ.2002;324:1313\u20131314","DOI":"10.1136\/bmj.324.7349.1313"},{"key":"2021121006391947600_R18","doi-asserted-by":"crossref","unstructured":"Turner S, Longworth A, Nunn T, Hewiit B, Choonara I. Use of off-label and unlicensed drugs in paediatric intensive care unit. Lancet.1996;347:549\u2013550","DOI":"10.1016\/S0140-6736(96)91182-4"},{"key":"2021121006391947600_R19","doi-asserted-by":"crossref","unstructured":"Avenel S, Bomkratz A, Dassieu G, Janaud JC, Danan C. The incidence of prescriptions without marketing product license in a neonatal intensive care unit. Arch Pediatr.2000;7:143\u2013147","DOI":"10.1016\/S0929-693X(00)88083-5"},{"key":"2021121006391947600_R20","doi-asserted-by":"crossref","unstructured":"Conroy S, McIntyre JM, Choonara I. Unlicensed and off-label drug use in neonates. Arch Dis Child Fetal Neonatal Ed.1999;80:F142\u2013F144","DOI":"10.1136\/fn.80.2.F142"},{"key":"2021121006391947600_R21","doi-asserted-by":"crossref","unstructured":"Turner S, Nunn AJ, Fielding K, Choonara I. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr.1999;88:965\u2013968","DOI":"10.1111\/j.1651-2227.1999.tb00191.x"},{"key":"2021121006391947600_R22","doi-asserted-by":"crossref","unstructured":"Gill AM, Leach HJ, Hughes J, Barker C, Nunn AJ, Choonara I. Adverse drug reactions in a paediatric intensive care unit. Acta Paediatr.1995;84:438\u2013442","DOI":"10.1111\/j.1651-2227.1995.tb13667.x"},{"key":"2021121006391947600_R23","doi-asserted-by":"crossref","unstructured":"Watson R. Drugs industry urged to develop medicines for children. BMJ.2002;324:563","DOI":"10.1136\/bmj.324.7337.563\/a"},{"key":"2021121006391947600_R24","doi-asserted-by":"crossref","unstructured":"Banner W. Off label prescribing in children\u2014a view from the United States. BMJ.2002;324:1290\u20131291","DOI":"10.1136\/bmj.324.7349.1290"},{"key":"2021121006391947600_R25","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Committee on Drugs. Uses of drugs not described in the package insert (off-label uses). Pediatrics.2002;110:181\u2013183","DOI":"10.1542\/peds.110.1.181"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/110\/5\/e52\/1116426\/pe11020000h1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/110\/5\/e52\/1116426\/pe11020000h1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T10:21:17Z","timestamp":1639131677000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/110\/5\/e52\/64517\/Unlicensed-and-Off-Label-Drug-Use-in-an-Australian"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11,1]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2002,11,1]]},"published-print":{"date-parts":[[2002,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.110.5.e52","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11,1]]}}}